테라퓨틱스MD (TXMD) 주가

테라퓨틱스MD(TXMD)는 NAS에 상장된 Healthcare · Drug Manufacturers - Specialty & Generic 기업입니다. 현재가 $2.19 (+0.46%), 시가총액 $22.69M, 52주 범위 $1.04 ~ $2.77.

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors.

핵심 지표

• 현재가: $2.19 (+0.46%)
• 시가총액: $22.69M
• 52주 최저~최고: $1.04 ~ $2.77
• 섹터: Healthcare
• 산업: Drug Manufacturers - Specialty & Generic
• 거래소: NAS

테라퓨틱스MD의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

테라퓨틱스MD 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 보유 (3.0 / 5)

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 0.87
• 순이익률: -18.83%
• 영업이익률: -108.51%

자주 묻는 질문